Vertex Pharmaceuticals Incorporated · NASDAQ:VRTX
Brennan Daniel J. received 795 Vertex Pharmaceuticals Incorporated shares as an award (Form 4)
Traded Oct 20, 2026 · Filed Oct 22, 2026
On Oct 20, 2026, Brennan Daniel J. (Director) received 795 Vertex Pharmaceuticals Incorporated shares as an award at US$503.47 for US$400K, leaving 795 shares. Filed Oct 22, 2026 (Form 4).
- Awarded
- 795 shares
- Price
- US$503.47
- Value
- US$400K
- Holding after
- 795 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 20, 2026 | Common Stock | Award | 795 | US$503.47 | 795 | Direct |
Source
Download original · View original at SEC